Leonardo Faoro

Department of Medicine, University of Chicago

Affiliated withUniversity of Chicago

Research Area

Biography

Leonardo Faoro has not added Biography.
If you are Leonardo Faoro and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 5	2011

Other Publications

Article	Year
Long-term analysis of the palliative benefit of 2-chlorodeoxyadenosine for myelofibrosis with myeloid metaplasia. European journal of haematology\| PubMed ID: 15654901	2005
Epidermal growth factor receptor - mediated signal transduction in the development and therapy of gliomas. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 17189397	2006
Paxillin is a target for somatic mutations in lung cancer: implications for cell growth and invasion. Cancer research\| PubMed ID: 18172305	2008
C. elegans as a model organism for in vivo screening in cancer: effects of human c-Met in lung cancer affect C. elegans vulva phenotypes. Cancer biology & therapy\| PubMed ID: 18340114	2008
Efficacy and safety of bevacizumab plus erlotinib for patients with recurrent ovarian, primary peritoneal, and fallopian tube cancer: a trial of the Chicago, PMH, and California Phase II Con... Gynecologic oncology\| PubMed ID: 18423560	2008
Protein kinase C beta in malignant pleural mesothelioma. Anti-cancer drugs\| PubMed ID: 18765998	2008
Lymphatic vessel density is not associated with lymph node metastasis in non-small cell lung carcinoma. Archives of pathology & laboratory medicine\| PubMed ID: 19061284	2008
PAX5 is expressed in small-cell lung cancer and positively regulates c-Met transcription. Laboratory investigation; a journal of technical methods and pathology\| PubMed ID: 19139719	2009
The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma. Cancer research\| PubMed ID: 19318576	2009
MET receptor tyrosine kinase. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer\| PubMed ID: 19861919	2009
MET/PKCbeta expression correlate with metastasis and inhibition is synergistic in lung cancer. Journal of carcinogenesis\| PubMed ID: 19955662	2009
EphA2 mutation in lung squamous cell carcinoma promotes increased cell survival, cell invasion, focal adhesions, and mammalian target of rapamycin activation. The Journal of biological chemistry\| PubMed ID: 20360610	2010
BRIDGE: an open-label phase II trial evaluating the safety of bevacizumab + carboplatin/paclitaxel as first-line treatment for patients with advanced, previously untreated, squamous non-smal... Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer\| PubMed ID: 21107290	2011
Randomized phase II study of bevacizumab in combination with chemotherapy in previously untreated extensive-stage small-cell lung cancer: results from the SALUTE trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 21502556	2011
Proteomic characterization of non-small cell lung cancer in a comprehensive translational thoracic oncology database. Journal of clinical bioinformatics\| PubMed ID: 21603121	2011
Targeted and Cytotoxic Therapy in Coordinated Sequence (TACTICS): Erlotinib, Bevacizumab, and Standard Chemotherapy for Non-Small-Cell Lung Cancer, A Phase II Trial. Clinical lung cancer\| PubMed ID: 22100149	2011